Filters
The combination of bictegravir and lenacapavir, taken orally once daily, performed better than current complex treatment regimens in the phase II ARTISTRY-1 trial of people with HIV who are virologically suppressed.
A novel infant microbiome formula (SIM03) containing unique Bifidobacterium bifidum and Bifidobacterium breve strains improves eczema severity and quality of life (QoL) in preschool children, shows a study by the Chinese University of Hong Kong (CUHK).
The investigational RNAi therapeutic plozasiran significantly reduced triglyceride levels in individuals with severe hypertriglyceridaemia (SHTG) who were at high risk for pancreatitis, according to the final results of the phase IIb SHASTA-2 trial.
Open-access esophagogastroduodenoscopy (OAE) facilitates a safe and timely evaluation of patients with nonalarming digestive issues in Singapore, according to a study.
Menopause is defined as the end of a woman’s menstrual cycles, which is confirmed with the absence of menstruation for 12 consecutive months.
Adding desloratadine to an isotretinoin regimen appears to reduce pruritus in acne, leading to a higher patient satisfaction, as shown in a study.
The oral Janus kinase (JAK) 1 preferential inhibitor filgotinib appears to be safe and effective in the treatment of Asian patients with ulcerative colitis, according to real-world data.
Testosterone replacement therapy in men with hypogonadism does not appear to reduce the risk of developing diabetes, according to the results of the TRAVERSE* substudy.
Older adults who have undergone percutaneous coronary intervention (PCI) may do well with a shortened dual antiplatelet therapy (DAPT) duration, which has been shown to reduce the risk of bleeding without increasing the risk of adverse clinical events in a network meta-analysis.
Increased screen time among children may be hurting their opportunities to talk and interact in their home environment, according to a study from Australia.
